#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Desmoid tumour Soft tissue necrosis Neuroendocrine carcinoma of the skin Cystic fibrosis respiratory infection suppression Hormone-dependent prostate cancer Rectal cancer Encephalitis autoimmune Plasma cell myeloma recurrent Pyoderma gangrenosum Turner's syndrome Cutaneous T-cell lymphoma refractory Loeys-Dietz syndrome Congenital myopathy Fabry's disease Mantle cell lymphoma stage III More trials…

    Learn about Rare Diseases

    Brain stem glioma – Life with Disease Pituitary-dependent Cushing’s syndrome Soft tissue sarcoma – Trials in Disease Alagille syndrome Testicular leiomyosarcoma – Trials in Disease Lymphatic malformation – Diagnostics Rosai-Dorfman syndrome Congenital nephrogenic diabetes insipidus – Basic Information Glycogen storage disease type I – Life with Disease Glycogen storage disease type V – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Terbinafine Hydrochloride Palonosetron Metoprolol Pioglitazone Hydrochloride Masitinib Protease MEGESTROL ACETATE Ruxolitinib Esmolol Hydrochloride IMB 101 Ioversol Livmoniplimab Atomoxetine Hydrochloride Lenograstim Brexpiprazole Radium Ra 223 Dichloride Alpha1H Doconexent Bedaquiline Colestyramine More therapies…

    Learn about Your Condition

    Delayed graft function Brain cancer metastatic Oesophageal cancer metastatic Hodgkin's disease Leiomyosarcoma recurrent Haematological malignancy Anal cancer Langerhans' cell histiocytosis Migraine with aura Aneurysm ruptured Ventricular fibrillation Post procedural hypotension Dyspnoea Diabetic autonomic neuropathy Malignant mast cell neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastric cancer

  • Comparing Remimazolam and Propofol for Deep Sedation in Patients Undergoing Endoscopic Ultrasound for Gastric and Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Gastric cancer
    Investigated Drugs:
    • Propofol
    • Remimazolam
    Italy

  • A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zanidatamab
    Spain

  • A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tislelizumab
    Austria Czechia France Italy Poland Spain

  • Study on [18F]-AlF-FAPI-74 for Staging Advanced Stomach Cancer in Patients Using PET/CT and Laparoscopy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    The Netherlands

  • Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    • Gastric cancer
    • Oesophageal cancer metastatic
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
    • Pembrolizumab
    Germany Greece Italy Poland Portugal Romania +1

  • Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Malignant neoplasm of ampulla of Vater
    • Salivary gland cancer
    Investigated Drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Denmark France Italy Spain
Previous Page
1 2 3 4 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!